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Abstract
Aims: We describe current treatment patterns for early pregnancy failure (EPF) among women enrolled in two
Michigan health plans.
Methods: We conducted a retrospective review of EPF treatment among Michigan Medicaid enrollees between
January 1, 2001, and December 31, 2004, and enrollees of a university-affiliated health plan between January 1,
2001, and December 31, 2005. Episodes were identified by the presence of a diagnostic code for EPF. Surgical
treatment was distinguished from nonsurgical management using procedure codes. Facility charges, procedure,
and place of service codes were used to determine whether a procedure was done in an office as opposed to an
operating room. Cases without a claim for surgical uterine evacuation were examined for a misoprostol phar-
macy claim and, if present, were classified as medical management. Cases without a procedure or pharmacy
claim were classified as expectant management.
Results: Respectively, we identified 21,311 and 1,493 episodes of EPF in the Medicaid and university-affiliated
health plan databases, respectively. Women enrolled in Medicaid were more likely to be treated with surgery
than were enrollees of the university-affiliated health plan (35.3 vs. 18.0%, respectively, p < 0.000). Among
Medicaid enrollees, only 0.5% of surgical evacuations occurred in the office, but office procedures were common
among enrollees of the university-affiliated health plan (30.5%, p < 0.000). The proportion of cases managed with
misoprostol was <1% in both groups. Caucasian race and age were both associated with having a surgical
uterine evacuation ( p < 0.001).
Conclusions: EPF is primarily being treated with expectant management or surgical evacuation in an operating
room and may not reflect evidence-based practices or patient preferences.
Introduction
Nearly 25% of women will have an early pregnancyfailure (EPF) at least once in their lifetime.1 Numerous
trials demonstrate that EPF can be safely treated with expec-
tant management, medical treatment with misoprostol, and
surgical uterine evacuation in either an operating room or an
office setting.2–14 Therefore, EFP care is an area in which pa-
tient preferences can be safely used to determine treatment in
most instances.
There are no population-based studies characterizing usual
treatment patterns in the United States for EPF. European and
Canadian studies show that most women undergo either
spontaneous passage of products or surgical management
in an operative suite.15,16 However, we and others have found
that some patients prefer other treatment options, such as
medical completion and office uterine evacuation.14,17–19 A
better understanding of current treatment practices can be
used to monitor quality of care and to encourage patient-
centered care models.
The purpose of this study was to describe current treatment
patterns among members of two health insurance systems in
Michigan: one with statewide enrollment and one with en-
rollment in Southeastern Michigan where treatment options
were known to include office uterine evacuations and medi-
cation completion. We hypothesized that medical treatment
with misoprostol and office uterine evacuations would be
uncommon statewide. Our secondary objective was to use
this sample to validate our classification methods that could
be applied to other populations.
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This study was approved by the Institutional Review Board
at the University of Michigan (IRB No. HUM00001495)
Claims data were used to identify patients with diagnostic
codes for EPF between January 1, 2001, and December 31,
2005, among beneficiaries of two health plans. There was no
patient contact during this study.
We used two administrative datasets to determine treat-
ment patterns. A statewide Medicaid dataset was used to ex-
amine overall treatment patterns across the state. Because we
knew that local treatment patterns included office uterine
evacuations as well as medical management with misopro-
stol, we also examined treatment patterns in a local university-
affiliated health plan. We used this university-affiliated plan to
examine how the introduction of office evacuations and mis-
oprostol therapy might affect overall treatment patterns. Fur-
thermore, as we had access to medical records in this system,
we used this data source to validate our classification scheme.
At the time of our data collection, the university-affiliated
health plan’s service area covered Southeastern Michigan and
included both teaching and community hospitals.
There were several differences in the types of data that were
available through these two sources. For instance, we were
able to obtain data on race only in the statewide plan and
plan type only in the university-affiliated plan. Further, the
statewide data included years 2001–2004, but the university-
affiliated plan provided 2005 data as well.
First, we identified EPF cases using the presence of diag-
nosis codes for early pregnancy failure (International Classifi-
cation of Diseases, 9th revision, codes 632, 634 and 637). All
diagnostic and procedural codes submitted to each health
plan were queried for the 42 days before and after the initial
EPF diagnosis. A repeat episode of EPF was based on a second
diagnosis code for EPF at least 180 days after the initial di-
agnosis.
Cases with a procedure code corresponding to a uterine
evacuation were classified as surgical (CPT codes 59812, 59820
or 59830). Surgical cases were further classified as either op-
erating room cases or office procedures using a combination of
facility codes, location codes, and the presence of a depart-
mental anesthesia charge. If there was a departmental anes-
thesia revenue code or an operating room revenue code, we
classified the procedure as occurring in an operating room.
Otherwise, if the facility type or place of service was a hospi-
tal, inpatient facility, or ambulatory surgical center and the
place of service was not an office, the procedure was also
classified as occurring in an operating room. Alternatively,
if the place of service was an office or if the facility type and
place of service were not hospitals and there were no inpatient
procedure or revenue codes, the procedure was classified as
occurring in an office. All other cases were coded as other=
unknown treatment location because of missing or conflicting
information.
Cases without procedure codes corresponding to a surgical
uterine evacuation were classified as either medical or ex-
pectant management. To distinguish the two, we searched for
pharmacy claims for misoprostol at any time during the 30
days prior to or after diagnosis. Cases with a pharmacy claim
for misoprostol were classified as medical management.
Cases with no pharmacy claim or CPT codes corresponding to
a surgical evacuation were classified as expectant manage-
ment. Additional information, such as patient demographics,
was collected when available.
Procedural and diagnostic codes for 6 weeks surrounding
the initial EPF episode were reviewed to identify evidence of
miscoding. For instance, if we identified claims for cesarean
section or vaginal delivery during that period, the accuracy of
the EPF-associated codes was questioned, and such cases
were excluded. If suspected or confirmed ectopic pregnancy
was evident in the submitted claims, these subjects were also
excluded.
We estimated we would obtain at least 300 cases per year in
each health plan. With these numbers, we would have the
power of 0.81 to detect a difference in proportions of 0.07 (i.e.,
0.10 vs. 0.17) when comparing 2 years within each health plan.
Descriptive statistics were used to describe treatment patterns
in each dataset, and differences between subgroups were ex-
amined using Pearson’s chi-square test. Categorical variables
were also compared using Pearson’s chi-square test.
Classification validation
We validated our classification methods by conducting
chart reviews on a random sample of 200 women treated in
the university-affiliated health plan. Because all treatment
options were readily available in this system, this sample was
expected to provide the diversity needed to estimate our
misclassification in the statewide health plan. The charts were
reviewed by a trained abstractor to verify diagnosis and
treatment modality. The validation process found 25 of 200
(12.5%) randomly selected charts did not have evidence of an
EPF despite having been assigned such a diagnosis code. In
80% of these cases, it appeared that the patient actually was
being seen for complaints or complications after undergoing
an induced abortion elsewhere, which may share a diagnosis
code with an ‘‘incomplete miscarriage.’’ Treatment of these
cases was correctly classified by our scheme as expectant
management, and none required additional treatment. When
examining the whole validation sample, we found the clas-
sification scheme accurately identified treatment type. Of the
cases we classified as surgery, 26 of 26 were actually treated
with surgery, and our scheme correctly identified the proce-
dure location in 76.9% cases. Only 1 case in the sample was
classified as medication treatment, which was correct. Of the
remaining 171 cases classified as expectant management, only
1 instance of misclassification was identified (0.6%). Overall,
we concluded our classification methods accurately differen-
tiated among surgery, medical management, and expectant
management and reasonably identified treatment location.
Results
A total of 25,087 cases of EPF were initially identified in the
state Medicaid database during the years of interest. Of these,
3,498 were found to have additional procedure or diagnosis
codes suggesting a coding error, and 278 had invalid diag-
nosis codes. Once these cases were excluded, 21,311 episodes
were analyzed. Using the same process, 1,493 cases were in-
cluded from the university-affiliated plan database.
Information on the demographic characteristics of our two
study groups was limited by the type of patient information
available (Table 1). Medicaid eligibility for pregnant women
in Michigan includes income <150% of the federal pov-
erty level. There was no income information for individual
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members of the university-affiliated health plan; however,
only 80 of 1,493 episodes were Medicaid enrollees serviced
under the university-affiliated health plan. Seventy-five per-
cent of the Medicaid group were under the age of 30, as
compared with 33% of participants enrolled in the university-
affiliated health plan ( p< 0.0001). Additionally, participants
in the university-affiliated health plan group were more likely
than women in the Medicaid group to be given the diagnosis
of complete abortion at presentation ( p< 0.0001).
Treatment patterns for the Medicaid enrollees and the
university-affiliated health plan groups are presented in Fig-
ure 1. Statewide, patients were more likely to be treated with a
surgical uterine evacuation than patients in the university-
affiliated system (35.3 vs. 18.0%, p< 0.000). This trend per-
sisted when we examined diagnostic subgroups. For instance,
having a complete abortion as opposed to an incomplete
abortion did not explain this difference. Medical treatment
with misoprostol was uncommon in both groups. The pro-
portion of surgical cases completed in an office setting was
0.5% in the statewide sample and 30.5% in the university-
affiliated plan sample ( p< 0.000) (Fig. 2).
Because enrollee race was available only in the statewide
Medicaid dataset, we examined patient factors associated with
surgical treatment in this group only (Table 2). Both race and
age were associated with treatment type. Whites were more
likely to be treated with surgery than either African Ameri-
cans or Hispanics ( p< 0.001). Further, African Americans and
Hispanics were more likely than whites to be diagnosed with
a completed spontaneous abortion at presentation (20.9 and
19.2% vs. 17.1%, respectively, p< 0.05). We were unable to
determine if this difference explained the difference in treat-
ment patterns, as the Medicaid data could only be provided
in aggregate. Further, women<20 years old were less likely to
be treated surgically than were 20–39-year-olds ( p< 0.025).
We examined both datasets for changes over time. In the
Medicaid group, misoprostol use was uncommon but in-
creased over the study period from 0.3% to 1.2% ( p< 0.001).
In the university-affiliated health plan, the proportion of cases
treated with surgery increased significantly from 16.5% to
32.6% ( p< 0.000) over the study period. This did not occur in
the statewide Medicaid group. The proportion of surgical
cases that appeared to be completed in an office setting did
not change over time in either group.
Discussion
Treatment options for EPF include expectant management,
medical completion with misoprostol, and surgical evacua-
tion in either an office or operative suite. Treatment patterns
in Michigan do not appear to reflect either evidence-based
practices2–13 or patient preferences.14,17–19 Rather, this study
suggests that women in Michigan are typically managed
either expectantly or with surgical uterine evacuation in an
operating room. Our findings also suggest patient factors,
such as age and race, may be associated with treatment type,
which has important implications for improving clinical care.
The main factor determining treatment patterns, however, is
most likely having access to providers offering a range of
treatment options.
Few studies have examined treatment preferences among
patients seen for EPF. Graziosi et al.18 interviewed women
diagnosed with EPF about their views on medical treatment
with misoprostol as compared to suction curettage. About 50%
of women interviewed would choose medical management if








19 4063 (19.1) 39 (2.6)
20–24 7477 (35.1) 120 (8.0)
25–29 4727 (22.2) 336 (22.5)
30–34 2739 (12.9) 475 (31.8)
35–39 1538 (7.2) 354 (23.7)
40þ 767 (3.5) 169 (11.4)
Race (Medicaid only)
African American 6970 (32.7) NA
Caucasian 12260 (57.5) NA
Hispanic 1520 (7.1) NA
Other=unknown 561 (2.6) NA
Diagnosis*
Missed=incomplete 17378 (81.5) 1102 (73.8)
Complete 3933 (18.5) 391 (26.2)
Plan type (local health plan only)
GradCare NA 60 (4.0)
HMO NA 1212 (81.2)
POS NA 149 (10.0)
PPO NA 12 (0.8)
Medicaid NA 61 (4.0)
*p< 0.001.
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its success rate exceeded 65%. Other studies have indicated
that many women prefer to avoid general anesthesia for
uterine evacuations.20,21 Our previous work suggests almost
half of women will choose to have their uterine evacuation
completed in an office setting.14 Based on these few studies,
one would expect a greater proportion of cases than was
identified in our study population to be managed with mis-
oprostol or office uterine evacuation.
Although this study was primarily designed to examine
overall treatment patterns, we found that women in the local
university-affiliated health plan are much more likely to have
an office uterine evacuation than women enrolled in Medic-
aid. We believe that the main explanation for this treatment
difference is that members of the university-affiliated health
plan have access to a network of providers offering this ser-
vice, whereas women in other parts of the state do not. It is
also possible that particular populations, such as low-income
or minority women, do not accept office procedures to the
same degree as women in the university-affiliated system, but
our study cannot assess such differences.
Although we were not surprised to find that office uter-
ine evacuations were uncommonly used, our previous work
with women experiencing EPF concluded that office proce-
dures are acceptable and sometimes preferable over the same
procedure in an operating room.14,19 After office uterine evac-
uations were introduced into our health system, there was a
surge of referrals indicating a high level of enthusiasm. Over
time, use decreased slightly as patients and providers be-
came familiar with the benefits and limitations of office pro-









































FIG. 1. Treatment patterns in Michigan by diagnosis and health plan.
Office Uterine Evacuations










































FIG. 2. Proportion of uterine evacuations performed in an
office setting by study year and health plan.
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operating suite offers substantial cost savings.1,14,22 Still, a
wide range of obstacles or disincentives probably limit the
availability of office uterine evacuations, including discom-
fort with office procedures in general or a lack of perceived
demand for such service. It is also possible that office uterine
evacuations for EPF are uncomfortably similar to induced
abortions, and some providers are reluctant to add the service
to their practice.23
Two identified trends could reflect the recent adoption of
newer treatment options by providers. First, the rate of sur-
gical treatment increased significantly over the study period
among the members of the university-affiliated health plan.
This trend occurred immediately after office uterine evacua-
tions were made widely available in this system. Because the
service is convenient to patient and providers, we anticipated
that it would move some patients out of the operating room
into the clinic for their procedure. However, its addition may
have effectively increased access to surgical treatment gener-
ally, resulting in more patients undergoing surgical comple-
tion as opposed to expectant or medical treatment. Increasing
the rate of surgical intervention may not improve the quality
of EPF care. Second, although misoprostol use was rare, its use
appeared to be increasing over the study period, which may
reflect early adoption of this treatment option. How the ad-
dition of misoprostol treatment will change overall treatment
patterns is uncertain.
Patient race and age were associated with being treated
with a surgical procedure among our study sample, which
has not been described previously. Although African Amer-
ican women and Hispanic women were more likely to have a
complete abortion based on ICD-9 coding, this study could
not assess how much of the disparity was explained by this
difference. It may be that these groups had a harder time
accessing care and, therefore, sought care after spontaneous
passage of products had already occurred. Alternatively,
there may be community-based influences causing treatment
preference differences between these groups. Our study could
not explain these findings, but these treatment differences
warrant further study.
After EPF, women express strong treatment preferences,24
yet providers still influence ultimate treatment choice.14,17
Although we found no study comparing treatment preference
or acceptance among women presented with all options,
several studies provide evidence that women will accept the
range of options addressed in this study.14,17–19,24,25 It is un-
likely that treatment patterns in Michigan only reflect patient
preference. Expanding treatment options to reflect patient
preferences and evidence-based practices could both improve
patient-centered care and possibly decrease healthcare re-
source use. However, changing clinical practices is a complex
challenge. Previous work consistently shows that adherence
to evidence-based practices is suboptimal.26–29 A number of
identified barriers to practice change might have particular
significance in EPF care, such as a lack of confidence that one
can actually perform the behavior or a belief that patients will
not accept the change.27 A better understanding of the existing
barriers to changing clinical practices is needed to effectively
encourage providers to broaden treatment choices for women
experiencing EPF.
Our study methodology has several limitations. First, this
methodology cannot explain the reasons underlying the iden-
tified treatment patterns, including associations with patient
race or socioeconomic status. We also could not distinguish
between patients who began with expectant management
but went on to have a surgical uterine evacuation and those
who primarily elected to have surgery. Further, administra-
tive codes are often difficult to interpret, misclassification is
common, and we would likely misclassify those who went
outside their insurance plan for treatment. For instance, we
doubted that the distinction between cases that were coded as
complete vs. incomplete abortions was very accurate; there-
fore, we do not comment on the appropriateness of the rela-
tively high number of surgical interventions done in the
complete group. We also found that >10% of women identi-
fied as having an EPF by diagnosis code had no evidence of it
upon chart review. Still, our classification scheme was able to
determine treatment type with a high degree of accuracy,
which was our primary objective. We opted not to attempt to
correct for this bias in the larger database for two reasons.
First, it is possible that the university-affiliated system is more
likely to see these cases because of referral patterns. Second,
we were primarily interested in validating our methods of
treatment classification, which was not affected by these cases.
Still, some degree of similar misclassification would probably
Table 2. Proportion of Cases Treated with Surgery by Patient Race and Age
Number (%) treated with surgery
Patient characteristics Incomplete=missed Complete
Race=ethnicity
White (n¼ 12,260)a 4,186=10,166 (41.2) 385=2,094 (18.4)
African American (n¼ 6,970) 2,046=5,511 (37.1)* 202=1,459 (13.8)*
Hispanic (n¼ 1,520) 441=1,228 (35.9)* 50=292 (17.1)
Age (years)
19 (n¼ 4,063) 1,136=3,305 (34.3)* 73=758 (9.6)*
20–39 (n¼ 16,481)b 5,464=13,446 (40.6) 556=3035 (18.3)
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be present in other data sources as well. Based on our find-
ings, this bias would likely increase the apparent proportion
of cases managed expectantly.
We anticipated some difficulty in determining procedure
location, which was somewhat confirmed during our valida-
tion process. Our validation process indicated that we over-
estimated the proportion of cases done in an office, at least
among enrollees of the university-affiliated health plan. We
also could not assess why a patient was prescribed misopro-
stol, and it is possible that it was used for another indica-
tion, such as hemorrhage. Again, this misclassification would
overestimate the proportion of cases managed medically. Gi-
ven the rarity of both office uterine evacuations and mis-
oprostol use among Medicaid enrollees, it is unlikely that the
presence of these biases changes our study’s fundamental
conclusions. Alternatively, it is possible that some providers
dispense misoprostol in their office, which would not have
been identified by our methods. We know that misoprostol is
not being dispensed from offices in the university-affiliated
health plan and suspect that this practice is uncommon else-
where in the state.
Conclusions
Women experiencing EPF in these Michigan health plans
appear predominantly to be treated expectantly or with sur-
gical uterine evacuation in an operating room. Use of mis-
oprostol or office uterine evacuations is very uncommon
despite evidence supporting their safety and effectiveness. As
several studies have consistently demonstrated high accep-
tance of both office evacuations and treatment with mis-
optrostol, the treatment pattern in Michigan is likely not
driven by patient preference. Because providers influence this
care pattern, a better understanding of provider attitudes to-
ward these newer treatment options is needed to encourage
the adoption of models of care that have proven safety, effi-
cacy, and patient acceptance.
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